Repertoire of antibodies against type 1 poliovirus in human sera

Journal of Virological Methods

Volumn 169, Issue 2, 2010, Pages 322-331

  Rezapkin, Gennady ^a   Neverov, Alexander ^a   Cherkasova, Elena ^a   Vidor, Emmanuel ^b   Sarafanov, Andrei ^a   Kouiavskaia, Diana ^a   Dragunsky, Eugenia ^a   Chumakov, Konstantin ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b SANOFI PASTEUR   (France)

Author keywords

Antigenic sites; Blocking ELISA; Epitopes; Monoclonal antibodies; Vaccine

Indexed keywords

EPITOPE; MATERNAL ANTIBODY; MONOCLONAL ANTIBODY; ORAL POLIOMYELITIS VACCINE; PENTAVAC; POLIOMYELITIS VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANIMAL CELL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNIZATION; NONHUMAN; POLIOMYELITIS VIRUS 1; PRIORITY JOURNAL; SEROLOGY; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ADULT; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; INFANT; NEUTRALIZATION TESTS; POLIOVIRUS; POLIOVIRUS VACCINES; VIROLOGY;

POLIOVIRUS;

EID: 77957021286     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2010.07.037     Document Type: Article

References (36)

1. Belov G.A., Fogg M.H., Ehrenfeld E. Poliovirus proteins induce membrane association of GTPase ADP-ribosylation factor. J. Virol. 2005, 79:7207-7216.
2. Blondel B., Crainic R., Fichot O., Dufraisse G., Candrea A., Diamond D., Girard M., Horaud F. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site. J. Virol. 1986, 57:81-90.
3. Brioen P., Sijens R.J., Vrijsen R., Rombaut B., Thomas A.A., Jackers A., Boeye A. Hybridoma antibodies to poliovirus N and H antigen. Arch. Virol. 1982, 74:325-330.
4. Chen Z., Earl P., Americo J., Damon I., Smith S.K., Zhou Y.H., Yu F., Sebrell A., Emerson S., Cohen G., Eisenberg R.J., Svitel J., Schuck P., Satterfield W., Moss B., Purcell R. Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:1882-1887.
5. Crainic R., Couillin P., Blondel B., Cabau N., Boue A., Horodniceanu F. Natural variation of poliovirus neutralization epitopes. Infect. Immun. 1983, 41:1217-1225.
6. Diamond D.C., Jameson B.A., Bonin J., Kohara M., Abe S., Itoh H., Komatsu T., Arita M., Kuge S., Nomoto A., Osterhaus A.D.M.A., Crainic R., Wimmer E. Antigenic variation and resistance to neutralization in poliovirus type 1. Science 1985, 229:1090-1093.
7. Dragunsky E.M., Ivanov A.P., Wells V.R., Ivshina A.V., Rezapkin G.V., Abe S., Potapova S.G., Enterline J.C., Hashizume S., Chumakov K.M. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy. J. Infect. Dis. 2004, 190:1404-1412.
8. Emini E.A., Jameson B.A., Lewis A.J., Larsen G.R., Wimmer E. Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies. J. Virol. 1982, 43:997-1005.
9. Emini E.A., Kao S.Y., Lewis A.J., Crainic R., Wimmer E. Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies. J. Virol. 1983, 46:466-474.
10. Evans D.M., Minor P.D., Schild G.S., Almond J.W. Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3. Nature 1983, 304:459-462.
11. Ferguson M., Minor P.D., Magrath D.I., Spitz M., Schild G.C. Antigenic characterization of poliovirus type 3 using monoclonal antibodies. Rev. Infect. Dis. 1984, 6(Suppl. 2):S510-S513.
12. Herold J., Andino R. Poliovirus requires a precise 5' end for efficient positive-strand RNA synthesis. J. Virol. 2000, 74:6394-6400.
13. Hogle J.M., Chow M., Filman D.J. Three-dimensional structure of poliovirus at 2.9 A resolution. Science 1985, 229:1358-1365.
14. Icenogle J.P., Minor P.D., Ferguson M., Hogle J.M. Modulation of humoral response to a 12-amino-acid site on the poliovirus virion. J. Virol. 1986, 60:297-301.
15. Ivanov A.P., Dragunsky E.M. ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccines. Expert Rev. Vac. 2005, 4:167-172.
16. Khurana S., Suguitan A.L., Rivera Y., Simmons C.P., Lanzavecchia A., Sallusto F., Manischewitz J., King L.R., Subbarao K., Golding H. Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med. 2009, 6:e1000049.
17. Lanzavecchia A., Bernasconi N., Traggiai E., Ruprecht C.R., Corti D., Sallusto F. Understanding and making use of human memory B cells. Immunol. Rev. 2006, 211:303-309.
18. Mallet E., Hoffenbach A., Salomon H., Blondeau C., Fritzell B. Primary immunization with combined, acellular DTaP-IPV-Act-HIB vaccine given at 2-3-4 or 2-4-6 months of age. The 15th European Societies for Paediatric Infectious Diseases 1997.
19. Minor P.D. Antigenic structure of poliovirus. Microbiol. Sci. 1986, 3:141-144.
20. Minor P.D. Antigenic structure of picornaviruses. Curr. Top. Microbiol. Immunol. 1990, 161:121-154.
21. Minor P.D., Ferguson M., Evans D.M., Almond J.W., Icenogle J.P. Antigenic structure of polioviruses of serotypes 1, 2 and 3. J. Gen. Virol. 1986, 67(Pt. 7):1283-1291.
22. Minor P.D., John A., Ferguson M., Icenogle J.P. Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. J. Gen. Virol. 1986, 67(Pt 4):693-706.
23. Minor P.D., Schild G.C., Bootman J., Evans D.M., Ferguson M., Reeve P., Spitz M., Stanway G., Cann A.J., Hauptmann R., Clarke L.D., Mountford R.C., Almond J.W. Location and primary structure of a major antigenic site for poliovirus neutralization. Nature 1983, 301:674-679.
24. Moynihan M., Ladefoged P., Mathiesen L. Enzyme-linked immunosorbent assay for detection of poliovirus antigen and antibody. Dev. Biol. Standard. 1980, 46:203-206.
25. Murphy R.M., Slayter H., Schurtenberger P., Chamberlin R.A., Colton C.K., Yarmush M.L. Size and structure of antigen-antibody complexes. Electron microscopy and light scattering studies. Biophys. J. 1988, 54:45-56.
26. Page G.S., Mosser A.G., Hogle J.M., Filman D.J., Rueckert R.R., Chow M. Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J. Virol. 1988, 62:1781-1794.
27. Rezapkin G., Dragunsky E., Chumakov K. Improved ELISA test for determination of potency of inactivated poliovirus vaccine (IPV). Biologicals 2005, 33:17-27.
28. Rezapkin G., Martin J., Chumakov K. Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method. Biologicals 2005, 33:29-39.
29. Roivainen M., Huovilainen A., Hovi T. Antigenic modification of polioviruses by host proteolytic enzymes. Arch. Virol. 1990, 111:115-125.
30. Sawyer L.A., McInnis J., Albrecht P. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or sabin strains. Biologicals 1993, 21:169-177.
31. Singer C., Knauert F., Bushar G., Klutch M., Lundquist R., Quinnan G.V. Quantitation of poliovirus antigens in inactivated viral vaccines by enzyme-linked immunosorbent assay using animal sera and monoclonal antibodies. J. Biol. Standard. 1989, 17:137-150.
32. Souvras M., Montagnon B., Fanget B., van Wezel A.L., Hazendonk A.G. Direct enzyme linked immunosorbent assay (ELISA) for quantification of poliomyelitis virus D-antigen. Dev. Biol. Standard. 1980, 46:197-202.
33. Traggiai E., Becker S., Subbarao K., Kolesnikova L., Uematsu Y., Gismondo M.R., Murphy B.R., Rappuoli R., Lanzavecchia A. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. 2004, 10:871-875.
34. WHO Manual for the Virological Investigation of Poliomyelitis 1997, WHO, Geneva, Switzerland.
35. Wood D.J., Heath A.B., Sawyer L.A. A WHO Collaborative study on assays of the antigenic content of inactivated poliovirus vaccines. Biologicals 1995, 23:83-94.
36. Yakovenko M.L., Cherkasova E.A., Rezapkin G.V., Ivanova O.E., Ivanov A.P., Eremeeva T.P., Baykova O.Y., Chumakov K.M., Agol V.I. Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties. J. Virol. 2006, 80:2641-2653.